ST6GALNAC1 and Familial prostate cancer: This shorter ST6GalNac1 protein is produced at higher levels in prostate cancer cells than the previously reported full-length protein; yet it is able to synthesise the sTn antigen which is linked to patient survival and metastasis, and controls cell adhesion (Munkley et al. 2015).